Citation: | TANG Chenquan, ZHOU Enchao. Effect observation of Yiqi Yangyin Tongluo Recipein the treatment of patients with diabetic nephropathy in stage Ⅲ to Ⅳ differentiated as syndrome of deficiency of qi and yin complicated with blood stasis[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 79-82. DOI: 10.7619/jcmp.20201463 |
[1] |
ZHANG L X, LONG J Y, JIANG W S, et al. Trends in chronic kidney disease in China[J]. N Engl J Med, 2016, 375(9): 905-906. doi: 10.1056/NEJMc1602469
|
[2] |
IWAI T, MIYAZAKI M, YAMADA G, et al. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study[J]. Clin Exp Nephrol, 2018, 22(2): 328-336. doi: 10.1007/s10157-017-1451-4
|
[3] |
黄力, 葛永纯. 免疫炎症与糖尿病肾病[J]. 肾脏病与透析肾移植杂志, 2019, 28(3): 247-251. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBY201903013.htm
|
[4] |
中华医学会糖尿病学分会微血管并发症学组. 糖尿病肾病防治专家共识(2014年版)[J]. 中华糖尿病杂志, 2014, 6(11): 792-801. doi: 10.3760/cma.j.issn.1674-5809.2014.11.004
|
[5] |
MOGENSEN C E, CHRISTENSEN C K, VITTINGHUS E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy[J]. Diabetes, 1983, 32(Suppl 2): 64-78. http://ndt.oxfordjournals.org/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=32/Supplement_2/64
|
[6] |
郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 2002: 1-41.
|
[7] |
丁小强, 朱加明. 糖尿病肾病诊治的研究进展、存在问题与展望[J]. 上海医学, 2018, 41(2): 73-77. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYX201802004.htm
|
[8] |
XU K, GUO L, BU H, et al. Daphnetin inhibits high glucose-induced extracellular matrix accumulation, oxidative stress and inflammation in human glomerular mesangial cells[J]. J Pharmacol Sci, 2019, 139(2): 91-97. doi: 10.1016/j.jphs.2018.11.013
|
[9] |
严倩华, 盛梅笑, 余江毅, 等. 芪葵颗粒对早期糖尿病肾病患者微量白蛋白尿及病情进展的影响[J]. 中国中西医结合杂志, 2018, 38(4): 430-434. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201804012.htm
|
[10] |
朱蓓, 宋卫国, 彭璘. 糖尿病肾病微炎症及氧化应激的中医药研究进展[J]. 江西中医药, 2016, 47(7): 72-74. https://www.cnki.com.cn/Article/CJFDTOTAL-JXZY201607031.htm
|
[11] |
GE C X, XU M X, QIN Y T, et al. Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation[J]. Food Funct, 2019, 10(5): 2970-2985. doi: 10.1039/C8FO01653D
|
[12] |
朱丽坤, 曹爽, 蒋仕林, 等. 黄芪注射液对db/db小鼠肾脏IL-1β、MCP-1和TNF-α的mRNA表达的影响[J]. 实验动物与比较医学, 2020, 40(1): 60-64. https://www.cnki.com.cn/Article/CJFDTOTAL-SHSY202001010.htm
|
[13] |
周恩超. 邹燕勤中医肾病学术经验传承与创新[M]. 南京: 江苏科学技术出版社, 2014: 31-33.
|
[14] |
蔡然, 崔建华. 黄芪注射液对早期糖尿病肾病患者尿白蛋白及细胞因子的影响[J]. 现代中西医结合杂志, 2016, 25(28): 3117-3119. doi: 10.3969/j.issn.1008-8849.2016.28.012
|
[15] |
杨柳, 李爱平, 张王宁, 等. 黄芪及含黄芪经方在治疗肾病方面的药理作用及临床应用研究进展[J]. 中草药, 2018, 49(14): 3419-3424. doi: 10.7501/j.issn.0253-2670.2018.14.031
|
[16] |
姜梦真, 任惠娟, 徐蕾, 等. 黄芪、水蛭有效成分对大鼠肾小球系膜细胞凋亡的影响[J]. 中成药, 2017, 39(5): 902-906. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201705004.htm
|
[17] |
杜珍芳, 黄敏, 张慧, 等. 益气养阴通络方治疗糖尿病肾病3期气阴亏虚夹瘀型患者的疗效观察[J]. 实用临床医药杂志, 2019, 23(15): 79-82. doi: 10.7619/jcmp.201915021
|
[18] |
王琳. 自拟黄芪参七汤治疗糖尿病肾病的效果及对患者血清miRNA-21和NF-κB表达的影响[J]. 中国实用医刊, 2019, 46(15): 109-113. http://d.wanfangdata.com.cn/periodical/zyyk201915037
|
[19] |
陈国宁, 卞海林. 依帕司他联合黄芪注射液对糖尿病肾病患者疗效和血液流变学的影响[J]. 实用临床医药杂志, 2011, 15(21): 100-101. doi: 10.3969/j.issn.1672-2353.2011.21.039
|
[20] |
张子力, 董慧. 水蛭及其有效成分治疗糖尿病肾脏病的研究进展[J]. 中西医结合研究, 2018, 10(2): 106-110. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXYH201802023.htm
|
[21] |
曲波. 黄蛭合剂治疗糖尿病肾病的临床研究[J]. 中国当代医药, 2012, 19(4): 59, 61. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGUD201204033.htm
|
[1] | YANG Zhongxin, ZHOU Ran, HUANG Zhichao, MEI Xiaohan, LI Yijian, YANG Xuefeng, LI Xiaoyu. Circ_0114427 targets microRNA-330-5p to regulate apoptosis and inflammatory response in lipopolysaccharide-induced alveolar epithelial cells[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 24-29, 36. DOI: 10.7619/jcmp.20232885 |
[2] | Ciren Yangzong, WANG Chaohua. Circ_0000885 regulates proliferation and apoptosis of gastric cancer cells by targeting miR-944[J]. Journal of Clinical Medicine in Practice, 2023, 27(19): 12-16, 21. DOI: 10.7619/jcmp.20231976 |
[3] | JIANG Xiuchun, WANG Dejun, YU He. Effect of luteolin on the proliferation, apoptosis and Hippo/Yes-related protein pathway of lung epithelial cells induced by bleomycin[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 83-87. DOI: 10.7619/jcmp.20211773 |
[4] | LI Yilong, LEI Kai, ZHANG Xiaozhao, DING Jingjian, ZHANG Shengtao, QIAO Wei, GUO Yongfeng. Study in effects of 1, 25-dihydroxyvitamin D3 on apoptosis and autophagy of colon cancer cells and its mechanism[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 5-9. DOI: 10.7619/jcmp.20211388 |
[5] | YU Xin, MI Zhihua, GAO Ju. Role of autophagy in apoptosis of neurons in brain tissue of rats induced by mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2019, 23(8): 12-15, 21. DOI: 10.7619/jcmp.201908003 |
[6] | LIU Hanyang, SONG Jun, ZHOU Yan, TANG Liming. Caffeine promotes apoptosis of gastric cancer by Caspase pathway[J]. Journal of Clinical Medicine in Practice, 2017, (13): 40-44. DOI: 10.7619/jcmp.201713011 |
[7] | JING FA, XIONG Shuming, LI Jianping. Mechanism of bisdemethoxycurcumin inhabits proliferation of hepatocellular carcinoma cell and induces apoptosis[J]. Journal of Clinical Medicine in Practice, 2016, (15): 43-46. DOI: 10.7619/jcmp.201615012 |
[8] | GAO Wenqiang, LIU Kun, ZHOU Yan, LIU Hanyang, TANG Liming. Effects of adenosine on proliferation and apoptosis in human gastric cancer cell line MGC-803[J]. Journal of Clinical Medicine in Practice, 2016, (13): 44-47,55. DOI: 10.7619/jcmp.201613013 |
[9] | WANG Hongmei, ZHANG Yunyu, SHI Peimin, XIE jing. Effect of paclitaxel in inhibiting proliferation of SHI-1 and induction of apoptosis[J]. Journal of Clinical Medicine in Practice, 2013, (21): 62-65. DOI: 10.7619/jcmp.201321017 |
[10] | SONG Hui, YANG Tao, GUO Yuanyuan, LI Fengmin, DONG Ping, YU Yibing, LIU Wen. Effects of uroacitide on proliferation and apoptosis of K562 cells in chronic myeloid leukemia[J]. Journal of Clinical Medicine in Practice, 2013, (14): 1-4. DOI: 10.7619/jcmp.201314001 |